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Methods and Materials the product is put through an acid work up and purification step, giving an 85% experimental yield [17] . Because commercially produced aa--AMS are no longer available, assembly of a library of aa--AMS would be beneficial for future research both at PSU and through collaboration with other research teams worldwide.
Introduction:
The correct assembly of amino acids in mature proteins is essential for specific translation of the genetic code. The intrinsic ability of aminoacyl--tRNA synthetases (aaRS) to selectively discriminate amongst a vast variety of amino acids, some differing by a single atom, plays a crucial role in ensuring the fidelity of the genetic code.
aaRS have evolved to selectively recognize their cognate substrates (ATP, amino acid and, tRNA aa ); substrate binding is then followed by catalysis of aminoacylation and release of aminoacyl--tRNA (aa--tRNA aa ). The aaRS have evolved separate distinct pockets in which selective aminoacylation of substrate occurs.
These active sites are formed through the tertiary structure of the protein and contain important amino acids whose side chains protrude in the active site and provide the necessary chemical environment for aminoacylation to occur [15] . 6 The specific spatial orientation of the amino acids and their side chains throughout the enzyme provides aaRS with a chemical and sterical method for discrimination amongst amino acids [2, 10, 12, 15, 16, 20, 22] . This feature of the enzyme architecture is present throughout the aaRSs structure. The orientation of amino acid side chains in the aaRS allows for specific chemical interactions with its cognate substrates. It provides the cell with a way to distinguish between structural and chemical differences in possible substrates. Structural rearrangements occurring solely when aaRS is allosterically affected by its cognate substrate provide a mechanism by which selective aminoacylation of substrate is achieved, and the fidelity to the genetic code is increased. The attachment of an amino acid to its cognate tRNA by aaRS represents the true step of coding, rather than the consequent incorporation of the amino acid into protein on the ribosome.
To achieve specificity, the aaRS will have to overcome the challenge of rejecting non--cognate substrates. Class I tRNA synthetases (IleRS, ValRS and LeuRS) have evolved a second site of catalytic activity for post amino acyl transfer editing, to increase its fidelity for faithful translation [8, 15] . Post transfer editing recognizes misacylated species of tRNA through both chemical and sterical properties not present on canonical products of aminoacylation. Isoleucyl--tRNA synthetase (IleRS) has to be able to reject leucyl--AMP (Leu--AMP), which differs structurally from isoleucyl--AMP (Ile--AMP) by the placement of one methyl group. Furthermore, IleRS has to be able to recognize the subtle structural differences of valyl--AMP (Val--AMP) whose side chain structure only deviates from Ile by the absence of one methyl group. IleRS uses a pre amino acyl transfer editing mechanism [7, 14, 21, 5] to ensure correct association of Ile to tRNA ile . Preceding the transfer of the amino acid to tRNA ile an editing event takes place, in which interactions within the active site of IleRS leads to the recognition and breakdown of noncanonical aa--AMP substrates.
Non--cognate Val--AMP gets hydrolyzed during pretransfer editing to avoid non-canonical association with tRNA ile [5, 7, 14, 21] .
Investigations into the basis of this remarkable display of selectivity depend heavily on the use of small molecules designed to inhibit aminoacylation [11, 16, 18, 21] . Small molecules such as these inhibitors can be designed to probe the nature of specific interactions, during important distinct intermediate steps of catalysis, within the enzymesubstrate complex ( Figure 1A) . The trapped complex can be crystallized and through X--ray diffraction experiments elucidate structures from which important protein--nucleic acid interactions can be studied. Due to the selective nature of aaRS, competitive inhibitors have to be carefully designed to avoid rejection by the enzyme. Competitive inhibitors such as these can also be used in rational drug design [11, 13, 14, 18] , by targeting bacterial translation. An example of such a drug is the antibiotic mupirocin that targets IleRS and leads to cell death [13, 14] . Mupirocin has also been used to solve crystal structures of IleRStRNA ile Mupirocin ( Figure 1A ). Due to the structural nature of mupirocin the available crystal structures have tRNA 3'--end (--CCA) protruding into the separate editing pocket of IleRS, [21] . Figure 1A provided by [21] and Figure 1B 
Methods and Materials:
Synthesis of Sulfamoyl chloride:
Reaction pathway for the formation of sulfamoyl chloride.
The synthesis of the sulfamoyl chloride intermediate followed methods
adapted from [1, 9] , where a mixture of formic acid and a catalytic amount of dimethylformamide (DMF) is added drop wise to solution of chlorosulfonyl-isocyanate in dichloromethane (DCM) and allowed to reflux for 15 min at 42 °C to yield sulfamoyl chloride (Scheme 1). The procedure for deprotection and formation of Ile--AMS adapted from an article by Castro--Pichel [4] , the ratio of TFA:H2O was changed to 6:2 instead of literature reported 5:2. This allows for a more efficient conversion from protected to deprotected state. The reaction proceeded at room temperature for 2 hours (Scheme 4).
Synthesis of 2',3'--O--isopropylidene--5'--O--sulfamoyladenosine:
Scheme 2. Synthesis of 2',3'--O--isopropylidene--5'--O--sulfamoyladenosine.
Purification of intermediates:
Products from each one of the above reactions, with the exception of the final deprotected product, were purified in a uniform fashion using silica gel size--13 exclusion chromatography (Figure 3b ). Where 60 mL silica powder was initially dissolved in a mixture of MeOH:CHCl3 (1:10) to give a gel, and subsequently loaded onto a column. Products from preceding reaction were dissolved using MeOH:CHCl3
(1:10), loaded onto the column and allowed to equilibrate. Elution of product was achieved by washing with MeOH:CHCl3 (1:10) and 2 mL column fractions were collected and monitored by cough spotting on silica thin layer chromatography (TLC) plates to determine retardation factor (RF) of product (Figure 3a) . The fractions containing the product with correct retardation factor were pooled and concentrated through rotary evaporation and used in ensuing synthesis step. RF corresponding to desired product reported in literature (1, 4, 9, 10) . 
Purification of 5'--O--[N--(L--isoleucyl)--sulfamoyl]adenosine:
Procedure for purification of final deprotected product was adapted from Heacock [10] , using size--exclusion chromatography. Dry Sephadex™ LH--20 was suspended in 70% MeOH/H2O (v/v) and allowed to swell before loading into a column. The product from the deprotection reaction was dissolved in 0.1 M ammonium formate and loaded onto the Sephadex™ column. Silica TLC (MeOH: CHCl3 (1:10) ) was used to determine which collected fraction contained the final product. The selected fractions containing the desired product were pooled and concentrated using rotary evaporation.
H--NMR analysis:
Proton nuclear magnetic resonance spectrums were acquired in deuterated dimethyl sulfoxide (DMSO--d6), at 400 MHz. 1 H--NMR spectra were collected from the final product and compared to a predicted spectra generated using ACD/HNMR predictor (version 5.12, Advanced Chemistry Development Inc.).
Activity assay:
Methods used for labeling of tRNA and aminoacylation activity assay adapted from (3, 19, 23, 24) . Where tRNA ile transcripts (received from Hari Bhaskaran) were radioactively labeled in the 3'--terminal internucleotide linkage using the activity of tRNA nucleotidyltransferase to incorporate a 32 P isotope. Upon exchange the tRNA transcript was heated to 80 o C and allowed to refold in the presence of MgCl2 (10mM) to its native state by slow cooling to ambient temperature. Labeled tRNA was then incubated with isoleucine, ATP, IleRS and Ile--AMS reaction aliquots from time points were quenched with P1 nuclease and subsequently spotted and separated on cellulose TLC. Fraction of Ile--AMS bound IleRS compared to free IleRS was determined through PhosphorImager and plotted vs time to yield Figure 9 .
Results:
Ile--AMS collection and quantification:
The final product was transferred to a pre--weighed vial (16.78996 g); after removal of the solvent by rotatory vacuum evaporation, the vial was weighed (17.02625 g)
demonstrating an addition of 0.23629 g attributed to the mass of final product. Ile--AMS molecular weight was estimated to be 463.16 g/mole, the reaction thus produced 0.51 mmoles of final product giving a %yield= (0.51/0.6)*100= 85%.
Ile--AMS 1 H--NMR:
Comparison between collected and theoretical spectra for Ile--AMS indicated structural similarities between the synthesized and theoretical compound ( Figure   4 ). Furthermore, the comparison between collected and predicted spectrums also revealed the presence of impurities within the synthesized compound due to the absence of corresponding peaks in the theoretical spectra. In the range of chemical shifts of 0.5--1.6 ppm the predicted and collected spectra integrates 9 protons and the peaks are very similar. The multiplets in the range 3. 
Activity assay:
The activity assay demonstrates inhibition activity of Ile--AMS towards its cognate substrate IleRS ( Figure 5 ). Inhibition of IleRS is also achieved by its 
Discussion:
The presence of Ile--AMS in the final product is elucidated in part by structural information deduced by comparison of collected and predicted 1 H--NMR spectrum ( Figure 4) . Combined with the canonical activity demonstrated during aminoacylation assay ( Figure 5 ) we can confirm a successful synthesis of Ile--AMS.
During the comparison of collected and predicted 1 H--NMR we see strong correlations between the two within the aromatic region. This region corresponds to 1 H attached to aromatic portions of the Ile--AMS; this suggests the presence of an adenosine like structure. However, we do see some differences within the region of exchangeable protons when comparing the collected spectrum to the predicted one. This is to be expected due to the nature of these exchangeable protons. The exaggeration of the peak at 3.5 ppm in the collected spectrum is due to impurities in the sample associated with H2O, and the peak at 2.5 ppm is dedicated to DMSO--d6.
The DMSO peak can stem from the sample being too dilute, this would further explain the level of noise observed in the region between 3.5--8 ppm. We must also take in to account the innate level of errors in the predicted 1 H--NMR spectra. The 
